Method
Level · gp.fundamentals.debt_to_revenue
Raw value 4672.98% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTOpus Genetics, Inc.'s latest supported as-filed period reports revenue of $755,000. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 4672.98% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -1582.78% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -73.80% · CORE
Level · gp.fundamentals.operating_margin
Raw value -2182.78% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 186.36% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Shares outstanding increased 38.9%; SBC / revenue moved 15527 bp higher.
2 evidence-backed componentsCash & equivalents changed +173.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
IRD · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001140361-26-036277SEC ↗8-KSep 9, 2026Period Sep 9, 20260001140361-26-035979SEC ↗4Sep 8, 2026Period Sep 8, 20260001140361-26-035913SEC ↗4Sep 8, 2026Period Sep 3, 20260001140361-26-035912SEC ↗10-QAug 6, 2026Period Jun 30, 20260001628280-26-054381SEC ↗8-KAug 6, 2026Period Aug 6, 20260001628280-26-053824SEC ↗4Jul 27, 2026Period Jul 23, 20260000905148-26-003354SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026Filed Sep 8, 2026 | Gallagher CamDirector | Option ExerciseDirect | 784,314 | $1 | $901,961 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 8, 2026 | Gallagher CamDirector | Option ExerciseDirect | 784,314 | $0 | $0 | Form 4 ↗ |
| Jul 23, 2026Filed Jul 27, 2026 | YERXA BENJAMIN RPresident | Open Market SaleDirect | 7,429 | $3 | $22,064 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Current assets changed +141.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +140.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +366.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +540.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +4433 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -85.0% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000905148-26-003353